Mizuho Maintains Outperform on CVS Health, Raises Price Target to $76

Benzinga · 04/09 11:51
Mizuho analyst Ann Hynes maintains CVS Health (NYSE:CVS) with a Outperform and raises the price target from $70 to $76.